In particular, G. lucidum exhibited anti-obesity activities by downregulating FAS, SCD1, and SREBP1c, and also displayed antihyperglycemic and antihyperinsulinemic activities by enhancing the activation of AMPK, ACC, IR, IRS, and Akt. Here, SREBF1 is linked to obesity due to melanocortin 4 receptor deficiency.